Secondary Logo

Most Popular Articles

Preclinical Assessment of CAR T-Cell Therapy Targeting the Tumor Antigen 5T4 in Ovarian Cancer

Owens, Gemma L.; Sheard, Victoria E.; Kalaitsidou, Milena; More

Journal of Immunotherapy. 41(3):130-140, April 2018.

Hemofiltration Successfully Eliminates Severe Cytokine Release Syndrome Following CD19 CAR-T-Cell Therapy

Liu, Yanfen; Chen, Xinfeng; Wang, Dao; More

Journal of Immunotherapy. 41(9):406-410, November/December 2018.

First-in-Human Treatment With a Dendritic Cell-targeting Lentiviral Vector-expressing NY-ESO-1, LV305, Induces Deep, Durable Response in Refractory Metastatic Synovial Sarcoma Patient

Pollack, Seth M.; Lu, Hailing; Gnjatic, Sacha; More

Journal of Immunotherapy. 40(8):302-306, October 2017.

Immunoglobulin G and Subclasses as Potential Biomarkers in Metastatic Melanoma Patients Starting Checkpoint Inhibitor Treatment

Diem, Stefan; Fässler, Mirjam; Bomze, David; More

Journal of Immunotherapy. 42(3):89-93, April 2019.

Treatment With Tumor-infiltrating Lymphocytes in Advanced Melanoma: Evaluation of Early Clinical Implementation of an Advanced Therapy Medicinal Product

Lindenberg, Melanie A.; Retèl, Valesca P.; van den Berg, Joost H.; More

Journal of Immunotherapy. 41(9):413-425, November/December 2018.

Efficacy and Safety of Pembrolizumab in Patients Enrolled in KEYNOTE-030 in the United States: An Expanded Access Program

Gangadhar, Tara C.; Hwu, Wen-Jen; Postow, Michael A.; More

Journal of Immunotherapy. 40(9):334-340, November/December 2017.

The Hexavalent CD40 Agonist HERA-CD40L Induces T-Cell–mediated Antitumor Immune Response Through Activation of Antigen-presenting Cells

Merz, Christian; Sykora, Jaromir; Marschall, Viola; More

Journal of Immunotherapy. 41(9):385-398, November/December 2018.

Autoimmune Granulomatous Inflammation of Lacrimal Glands and Axonal Neuritis Following Treatment With Ipilimumab and Radiation Therapy

Ileana Dumbrava, Ecaterina; Smith, Veronica; Alfattal, Rasha; More

Journal of Immunotherapy. 41(7):336-339, September 2018.

Chimeric Antigen Receptor-modified Donor Lymphocyte Infusion Improves the Survival of Acute Lymphoblastic Leukemia Patients With Relapsed Diseases After Allogeneic Hematopoietic Stem Cell Transplantation

Wang, Tao; Gao, Lei; Hu, Xiaoxia; More

Journal of Immunotherapy. 42(3):81-88, April 2019.

Characterization of Postinfusion Phenotypic Differences in Fresh Versus Cryopreserved TCR Engineered Adoptive Cell Therapy Products

Nowicki, Theodore S.; Escuin-Ordinas, Helena; Avramis, Earl; More

Journal of Immunotherapy. 41(5):248-259, June 2018.

DNA Vaccine Encoding HPV16 Oncogenes E6 and E7 Induces Potent Cell-mediated and Humoral Immunity Which Protects in Tumor Challenge and Drives E7-expressing Skin Graft Rejection

Chandra, Janin; Dutton, Julie L.; Li, Bo; More

Journal of Immunotherapy. 40(2):62-70, February/March 2017.

Immunologic Monitoring of Cancer Vaccine Therapy: Results of a Workshop Sponsored by the Society for Biological Therapy

Keilholz, Ulrich; Weber, Jeffrey; Finke, James H.; More

Journal of Immunotherapy. 25(2):97-138, March-April 2002.

CD19 Isoforms Enabling Resistance to CART-19 Immunotherapy Are Expressed in B-ALL Patients at Initial Diagnosis

Fischer, Jeannette; Paret, Claudia; El Malki, Khalifa; More

Journal of Immunotherapy. 40(5):187-195, June 2017.

Evidence for Efficacy of Treatment With the Anti-PD-1 Mab Nivolumab in Radiation and Multichemorefractory Advanced Penile Squamous Cell Carcinoma

Trafalis, Dimitrios T.; Alifieris, Constantinos E.; Kalantzis, Anastasios; More

Journal of Immunotherapy. 41(6):300-305, July/August 2018.

Ex Vivo-expanded Natural Killer Cells Derived From Long-term Cryopreserved Cord Blood are Cytotoxic Against Primary Breast Cancer Cells

Nham, Tina; Poznanski, Sophie M.; Fan, Isabella Y.; More

Journal of Immunotherapy. 41(2):64-72, February/March 2018.

Outcomes of Adoptive Cell Transfer With Tumor-infiltrating Lymphocytes for Metastatic Melanoma Patients With and Without Brain Metastases

Mehta, Gautam U.; Malekzadeh, Parisa; Shelton, Thomas; More

Journal of Immunotherapy. 41(5):241-247, June 2018.

Systematic Evaluation of Neurotoxicity in Children and Young Adults Undergoing CD22 Chimeric Antigen Receptor T-Cell Therapy

Shalabi, Haneen; Wolters, Pamela L.; Martin, Staci; More

Journal of Immunotherapy. 41(7):350-358, September 2018.

Analysis and Characterization of Antitumor T-cell Response After Administration of Dendritic Cells Loaded With Allogeneic Tumor Lysate to Metastatic Melanoma Patients

Bercovici, Nadege; Haicheur, Nacilla; Massicard, Severine; More

Journal of Immunotherapy. 31(1):101-112, January 2008.

Evaluating for Pseudoprogression in Colorectal and Pancreatic Tumors Treated With Immunotherapy

Parseghian, Christine M.; Patnana, Madhavi; Bhosale, Priya; More

Journal of Immunotherapy. 41(6):284-291, July/August 2018.

Whole Recombinant Saccharomyces cerevisiae Yeast Expressing Ras Mutations as Treatment for Patients With Solid Tumors Bearing Ras Mutations: Results From a Phase 1 Trial

Cohn, Allen; Morse, Michael A.; O’Neil, Bert; More

Journal of Immunotherapy. 41(3):141-150, April 2018.

Evaluation of Ipilimumab in Combination With Allogeneic Pancreatic Tumor Cells Transfected With a GM-CSF Gene in Previously Treated Pancreatic Cancer

Le, Dung T.; Lutz, Eric; Uram, Jennifer N.; More

Journal of Immunotherapy. 36(7):382-389, September 2013.

Human Inflammatory Cells Within the Tumor Microenvironment of Lung Tumor Xenografts Mediate Tumor Growth Suppression in Situ that Depends on and Is Augmented by Interleukin-12

Sugiyama, Yasuyuki; Kato, Motohisa; Chen, Fang-An; More

Journal of Immunotherapy. 24(1):37-45, January-February 2001.

PD-1 Blockade Augments Th1 and Th17 and Suppresses Th2 Responses in Peripheral Blood From Patients With Prostate and Advanced Melanoma Cancer

Dulos, John; Carven, Gregory J.; van Boxtel, Susan J.; More

Journal of Immunotherapy. 35(2):169-178, February-March 2012.

Donor-derived CAR-T Cells Serve as a Reduced-intensity Conditioning Regimen for Haploidentical Stem Cell Transplantation in Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia: Case Report and Review of the Literature

Zhang, Cheng; Kong, Pei-Yan; Li, Shiqi; More

Journal of Immunotherapy. 41(6):306-311, July/August 2018.

Wilms Tumor Gene (WT1) Peptide–based Cancer Vaccine Combined With Gemcitabine for Patients With Advanced Pancreatic Cancer

Nishida, Sumiyuki; Koido, Shigeo; Takeda, Yutaka; More

Journal of Immunotherapy. 37(2):105-114, February/March 2014.

Retrospective Analysis of the Safety and Efficacy of High-dose Interleukin-2 After Prior Tyrosine Kinase Inhibitor Therapy in Patients With Advanced Renal Cell Carcinoma

Lam, Elaine T.; Wong, Michael K. K.; Agarwal, Neeraj; More

Journal of Immunotherapy. 37(7):360-365, September 2014.

Utilizing T-cell Activation Signals 1, 2, and 3 for Tumor-infiltrating Lymphocytes (TIL) Expansion: The Advantage Over the Sole Use of Interleukin-2 in Cutaneous and Uveal Melanoma

Tavera, René J.; Forget, Marie-Andrée; Kim, Young Uk; More

Journal of Immunotherapy. 41(9):399-405, November/December 2018.

A Phase I Clinical Trial of Vaccination With KIF20A-derived Peptide in Combination With Gemcitabine For Patients With Advanced Pancreatic Cancer

Suzuki, Nobuaki; Hazama, Shoichi; Ueno, Tomio; More

Journal of Immunotherapy. 37(1):36-42, January 2014.

Control of Established Melanoma by CD27 Stimulation Is Associated With Enhanced Effector Function and Persistence, and Reduced PD-1 Expression of Tumor Infiltrating CD8+ T Cells

Roberts, Drew J.; Franklin, Nathan A.; Kingeter, Lara M.; More

Journal of Immunotherapy. 33(8):769-779, October 2010.

Establishment and Large-scale Expansion of Minimally cultured “Young” Tumor Infiltrating Lymphocytes for Adoptive Transfer Therapy

Itzhaki, Orit; Hovav, Einat; Ziporen, Yaara; More

Journal of Immunotherapy. 34(2):212-220, March 2011.

Pharmacological Evaluation of Humanized Anti-Epidermal Growth Factor Receptor, Monoclonal Antibody h-R3, in Patients With Advanced Epithelial-Derived Cancer

Crombet, Tania; Torres, Leonel; Neninger, Elia; More

Journal of Immunotherapy. 26(2):139-148, March-April 2003.

Sequencing Treatment in BRAFV600 Mutant Melanoma: Anti-PD-1 Before and After BRAF Inhibition

Johnson, Douglas B.; Pectasides, Eirini; Feld, Emily; More

Journal of Immunotherapy. 40(1):31-35, January 2017.

Constitutively Active STAT5b Induces Cytokine-Independent Growth of the Acute Myeloid Leukemia–Derived MUTZ-3 Cell Line and Accelerates Its Differentiation Into Mature Dendritic Cells

Bontkes, Hetty J.; Ruizendaal, Janneke J.; Kramer, Duco; More

Journal of Immunotherapy. 29(2):188-200, March-April 2006.

Effect of Serum and Antioxidants on the Immunogenicity of Protein Kinase C-Activated Chronic Lymphocytic Leukemia Cells

Hammond, Caitlin; Shi, Yonghong; Mena, Jenny; More

Journal of Immunotherapy. 28(1):28-39, January-February 2005.

A Phase I Study of High-Dose Interleukin-2 With Sorafenib in Patients With Metastatic Renal Cell Carcinoma and Melanoma

Monk, Paul; Lam, Elaine; Mortazavi, Amir; More

Journal of Immunotherapy. 37(3):180-186, April 2014.